SODIUM BICARBONATE ANTACID- sodium bicarbonate tablet 
Richmond Pharmaceuticals, Inc.

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

Sodium Bicarbonate 325 mg

Drug Facts

Active ingredient                                     Purpose

(in each tablet)

Sodium bicarbonate 5 gr (325 mg) .......      Antacid

Purpose

Purpose                      Antacid



Keep out of reach of children

Keep out of reach of children.

Uses

relieves



Warnings

Warnings

Ask a doctor before use if you have a sodium restricted diet

Ask a doctor or pharmacist before use of you are

-taking a prescription drug. Antacids may interact with  certain prescription drugs.

Stop use and ask a doctor if symptoms last more than 2 weeks

If pregnant or breast-feeding, ask a health professional before use.

This package for households without young children. 

Each tablet contains: sodium 89 mg

Directions

Directions

Inactive ingredients

Inactive ingredients

croscarmellose sodium, microcrystalline cellulose, stearic acid

Storage

Storage

store at room temperature 15 o - 30 o C (59 o - 86 o F)

Questions?

call 804-270-4498, 8.30 am-4.30 pm ET, Monday - Friday
TAMPER EVIDENT: DO NOT USE IF IMPRINTED SAFETY SEAL UNDER CAP IS BROKEN OR MISSING

Principal Display Panel

Principal Display Panel

Sodium Bicarbonate Antacid Tablet

5 ​​gr (325 mg)

1000 White Tablets

NDC-  54738-035-03

image1

SODIUM BICARBONATE ANTACID 
sodium bicarbonate tablet
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:54738-035
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SODIUM BICARBONATE (UNII: 8MDF5V39QO) (SODIUM CATION - UNII:LYR4M0NH37) SODIUM BICARBONATE325 mg
Inactive Ingredients
Ingredient NameStrength
CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  
CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  
STEARIC ACID (UNII: 4ELV7Z65AP)  
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
TALC (UNII: 7SEV7J4R1U)  
Product Characteristics
ColorwhiteScoreno score
ShapeROUND (Tablet) Size9mm
FlavorImprint Code AP;120
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:54738-035-031000 in 1 BOTTLE; Type 0: Not a Combination Product06/01/2015
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalpart33106/01/2015
Labeler - Richmond Pharmaceuticals, Inc. (043569607)
Registrant - Advance Pharmaceutical Inc. (078301063)
Establishment
NameAddressID/FEIBusiness Operations
Advance Pharmaceutical Inc.078301063manufacture(54738-035)

Revised: 11/2017
Document Id: 5cec472c-8a20-32e5-e053-2991aa0a3222
Set id: e0b2f0d3-3849-4bdf-b3d4-e14e520e36ce
Version: 2
Effective Time: 20171101
 
Richmond Pharmaceuticals, Inc.